IQV vs SNSE · P/E 23, rev $16.31B vs $18.6M cap
IQVIA Holdings Inc (IQV) versus Sensei Biotherapeutics Inc (SNSE) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Sensei Biotherapeutics Inc (SNSE) is a biotechnology company listed on NASDAQ.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
SNSE does not have a complete income-statement cache yet.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. SNSE currently screens at market cap $18.6M.
Not investment advice. Open the IQV and SNSE stock pages for the full models.
Not investment advice.